Skip to main content
. 2020 Sep 14;9(9):865. doi: 10.3390/antiox9090865

Table 1.

List of phytochemicals reported to regulate NRF2 signaling epigenetically.

Sl No. Phytochemical Chemical Name Epigenetic Mechanism of Nrf2 Regulation Molecular Targets Cell Type Reference
1. 3,3′-diindolylmethane 3,3′-Methylenebis(1H-indole) Decreased methylation of CpG sites in the promoter region of mouse Nfe2l2 Suppressed mRNA and protein expression of Dnmt1, Dnmt3a, and Dnmt3b; inhibited protein expression of Hdac2 and Hdac3 TRAMP-C1 prostate cells [79]
2. Apigenin 5,7-Dihydroxy-2-(4hydroxy-phenyl)-4H-chromen-4-one Decreased Nfe2l2 hyper-methylation; induced expression of miR-101, targeting Nfe2l2 mRNA Inhibited Dnmt1, Dnmt3a and Dnmt3b; inhibited Hdacs; induced miR101 Mouse epidermal JB6 P+ cells BEL-7402/ADM cells [80,81]
3. Corosolic acid 2α,3β-2,3-dihydroxyurs-12-en-28-oic acid Decreased Nfe2l2 hypermethylation; increased histone H3 lysine 27 acetylation; decreased H3 lysine 27 trimethylation Decreased levels of Dnmt1, Dnmt3a and Dnmt3b; reduced levels of Hdac1, Hdac2, Hdac3, Hdac4, Hdac7 and Hdac8 TRAMP-C1 prostate cells [82]
4. Curcumin 1, 7-bis (4-hydroxy-3-methoxy-phenyl)-1, 6 heptadiene-3, 5-dione Decreased Nfe2l2 hypermethylation Inhibited enzymatic activity of Dnmt enzymes TRAMP-C1 prostate cells [83]
5. Delphinidin 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl) chromenium Demethylation of 15 CpG sites in the mouse Nfe2l2 promoter region Decreased protein expression of Dnmt1, Dnmt3a, and class I/II Hdacs Mouse epidermal JB6 P+ cells [84]
6. Fucoxanthin 3,5′-Dihydroxy-8-oxo-6′,7′-didehydro-5,5′,6,6′,7,8-hexahydro-5,6-epoxy-β,β-caroten-3′-yl acetate Decreased Nfe2l2 hypermethylation Reduced Dnmt activity Mouse epidermal JB6 P+ cells [85]
7. Luteolin 2-(3,4dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one Decreased NFE2L2 hypermethylation Decreased expression of DNMT1, DNMT3A and DNMT3B; decreased HDAC1, HDAC2, HDAC3, HDAC6, HDAC7; reduced activities of DNMTs and HDACs; increased ten-eleven translocation 1, 2 and 3 (TET1, TET2, and TET3) Human colon cancer cells and SNU-407 cells [86,87]
8. Pelargonidin 3,5,7-Trihydroxy-2-(4hydroxyphenyl) chromenium Decreased methylated CpGs in Nfe2l2 promoter Decreased Dnmt1 and Dnmt3b expression; reduced levels of Hdacs 1–4 and Hdac7 JB6 P+ cells [88]
9. Polydatin 3-Hydroxy-5-[(E)-2-(4-hydroxyphenyl)vinyl] phenyl β-d-glucopyranoside Enhanced miR-200a targeting KEAP1 to activate NRF2 signaling Increased miR-200a expression under high fructose induction; downregulated KEAP1 mRNA and protein Buffalo rat liver (BRL-3A) and human HepG2 cells [89]
10. Reserpine Methyl 18β-hydroxy-11,17α-dimethoxy-3β,20α-yohimban-16βcarboxylate 3,4,5-trimethoxybenzoate Decreased proportion of methylated CpG sites in the Nfe2l2 promoter Concentration-dependent decreased mRNA and protein expression of Dnmt1, Dnmt3a, and Dnmt3b JB6 P+ Cell [90]
11. Resveratrol 3,4′,5-trihydroxystilbene Decreased methylation of the NFE2L2 promoter Inhibited expression and activity of DNMT1, DNMT3a, and DNMT3b; miR93 implicated HepG2 cells and estradiol-induced breast cancer [91,92]
12. Sulforaphane 1-Isothiocyanato-4-(methanesulfinyl)butane CpG demethylation and histone acetylation at the Nfe2l2 promoter; lncRNA upregulation Inhibition of Dnmt1, Dnmt3a, Dnmt3b, Hdacs 1–5, and Hdac7; upregulated functional pseudogene NMRAL2P JB6 P+ cells; TRAMP C1 cells; human colon cancer cells [93,94]
13. Tanshinone IIA 1,6,6-trimethyl-8,9- dihydro-7H-naphtho [1,2-g] benzofuran-10,11-dione Decreased methylated CpGs in Nfe2l2 promoter; increased recruitment of RNA polymerase complex II at the NFE2L2 transcription start site Decreased mRNA and protein levels of HDAC1, HDAC3, and HDAC8, as well as DNMT1, DNMT3a, and DNMT3b; induced expression of TET2 JB6 P+ cells, human normal hepatocyte and Hepa RG cells; rifampicin-induced liver injury in mice [95,96]
14. Taxifolin (2S,3S)-2-(3,4dihydroxy-phenyl)-3,5,7-trihydroxy-2,3dihydro-4H-chromen-4-one Decreased proportion of methylated CpGs in the Nfe2l2 promoter Reduced protein levels of Dnmt1, Dnmt3a and Dnmt3b as well as Hdacs 1, 3, 4, and 8 JB6 P+ cells [97]
15. Ursolic acid (3β)-3-Hydroxyurs-12-en-28-oic acid Nfe2l2 mouse promoter demethylation; increased acetylation and K4 monomethylation of histone H3 in human cells Reduced DNMT1 and DNMT3a protein levels; inhibited expression of HDACs 1-3 and 8 (Class I) and HDAC 6 and 7 (Class II); induced Setd7 JB6 P+ cells PC3 and LnCaP cells [98,99]
16. γ Tocopherol–rich mixture of tocopherols (γ-TmT) (2R)-2,5,7,8-tetramethyl-2-[ (4R,8R)-4,8,12-trimethyl-tridecyl]-6-chromanol Reversed hyper-methylation in the Nfe2l2 promoter Inhibited protein levels of Dnmt1, Dnmt3a, and Dnmt3b Prostate tissues of C57BL/TGN TRAMP mice [100]
17. Z-Ligustilide (3E)-3-butylidene-4,5-dihydro-2-benzofuran-1-one Decreased methylation of the first five CpGs of the Nfe2l2 promoter Inhibited Dnmt activity TRAMP C1 cells [101]